Clinical Research and Innovation

research department

Molecular Imaging Research Department

Molecular imaging is the visualization of cellular and molecular level activities taking place within the body. The Molecular Imaging Research Department is working to elucidate the pathology of diseases and develop new drugs by utilizing a diagnostic technology called "PET" that visualizes biological functions.
The main missions of our research department are the manufacturing of investigational drugs and the implementation of clinical trials related to PET, clinical research, and the development and quality control of imaging and analysis methods. As a municipal hospital, we also strive to create a system that provides the public with cutting-edge research results obtained through clinical research. We will make maximum use of the know-how we have cultivated in drug discovery, imaging, and quality control to develop safe and highly effective diagnostic techniques using PET, and contribute to the advancement of medicine.

Intractable Disease Research Department

The intractable disease research department uses donations from Actelion Pharmaceuticals Japan Co., Ltd. (currently Janssen Pharma K.K.) to conduct genome analysis and gene expression analysis on patients suspected of having genetic abnormalities for diagnosis. In addition to clarifying the onset mechanism after anonymizing this information, we also worked on intractable diseases such as Parkinson's disease and amyotrophic lateral sclerosis, acute myeloid leukemia, oral cancer, and anemia-complicated heart failure. We are also engaged in research aimed at developing new treatments and diagnostic methods for diseases.

Neurovascular Research

We are actively working with researchers and companies to manage clinical trials and multi-center joint research on cerebrovascular treatment and develop medical devices related to cerebrovascular treatment (device development research).

Hearing Research

Optical topography (fNIRS) that can be performed even in children with cochlear implants, focusing on (1) the development of the visual cortex (response to audio stimuli) and (2) audiovisual integration (synchronous activity between the auditory and visual cortices) after cochlear implant surgery We will conduct clinical research to evaluate brain function using a multi-channel electroencephalograph and lead to the development of new rehabilitation programs.

Rheumatology

To promote the clinical development of "anti-PD-1 agonist antibody therapy" and "early diagnosis marker for inflammatory diseases" being researched by the Immunology Research Department, Advanced Medical Research Center, Kobe Medical Industry Development Organization , in cooperation with the same research department, build related clinical infrastructure, plan, implement and manage clinical research, build evidence related to immune diseases, etc., and provide feedback for the development of new therapeutic methods and diagnostic methods. increase.

Regenerative Medicine

Director

Asuka Morizane
(Asuka Morizane)

We are conducting research on cell transplantation therapy for central nervous system diseases using stem cells, and are working on research on post-transplantation immune response control. First of all, we will promote the clinical application of regenerative medicine for Parkinson's disease in the field of neurology, which is our specialty. .

Department of Clinical Pharmacy

The Clinical Pharmacy Research Department finds solutions to various themes related to the appropriate use of medicines through clinical pharmacy research, proposes and implements them in actual clinical settings, and verifies their effectiveness.In addition, we provide clinical pharmacological support to doctor in their clinical research by proposing pharmacokinetic and pharmacodynamic (PK/PD) protocols, measuring drug concentrations, and carrying out pharmacokinetic analysis.
Additionally, based on the "Agreement on Educational and Research Cooperation" concluded with the Kobe Gakuin University Graduate School of Pharmaceutical Sciences, we will also work to develop researchers.

Clinical AI Research Department

The Clinical AI Research Department is conducting clinical research using artificial intelligence (AI) to provide higher quality medical care. In parallel with this, we are promoting the use of AI in daily clinical activities to improve the quality and safety of medical care and to streamline operations. By working closely with the University Hyogo Prefecture, we have established a system that allows us to analyze medical data safely and at low cost.

Ongoing research

Department of Surgery

Director

Noboru Ohshima
(Nobu Ohshima)

With the motto of "Turning Surgery into Science," our research department aims to build a research system that will lead to the development of new diagnostic and treatment methods, as well as medical equipment and systems, based on the clinical outcomes of minimally invasive surgery, primarily robotic surgery. Furthermore, by producing storable biomaterials from surgical specimens and integrating various clinical information generated by our hospital's advanced medical functions into them, we will enhance their value as "living research samples wrapped in medical information" and provide them to the medical cluster.

In this way, we aim to utilize the "Patient-Derived Material for Medical Innovation Hub (PD-MiH)" as a mechanism for the synergistic development of "surgery" and "research," and to contribute to various research fields.

Research Promotion Division

The Research Promotion Division is an organization that provides professional and practical support for the diverse research activities at our hospital. It is made up of the Project Promotion Department and the Academic Research Promotion Department, and handles a wide range of tasks, from supporting the development of medical devices and pharmaceuticals to promoting academic activities within the hospital. Both departments have the mission of solving problems and questions originating from the clinical field, and will strive to promote high-quality research activities and produce results in order to disseminate our hospital's high clinical capabilities to society.

Project Promotion Department

We introduce on-site clinical observation to link clinical issues to research themes and promote the development of medical devices and pharmaceuticals. We also provide expert support for the planning and operation of cases in which our hospital doctor are in charge of coordinating the office for investigator-initiated doctor trials or the principal investigator/research office for multi-center collaborative research.

We also focus on data management using REDCap, a data collection and management system, to promote projects such as clinical research.

Academic Research Promotion Department

We support various in-house activities related to academic research (research consultations, statistical analysis consultations, data entry, illustration creation, English proofreading, etc.).

Administrative support department

Management support department

In order to conduct ethical and scientifically high-quality clinical trials (trials) safely and smoothly, the Administration Support Department is centered on a management department staffed by staff with specialized knowledge of clinical research and a clinical research coordinator (CRC). It consists of support departments that have I would like to contribute to the provision of high-quality medical care while protecting the rights and safety of patients by making full use of my advanced expertise.

Quality control department

Quality control department

The Quality Control Department is a department whose purpose is to ensure the quality of clinical research. Collaborate with various departments within the hospital and appropriately manage clinical research conducted by researchers based on various legal guidelines as a hospital to protect patients who participate in clinical research and ensure reliable clinical research. We will strive to carry out

Administrative department

administrative department

The administration department is in charge of general clerical work such as contracts related to clinical research and trials, document management, aggregation of safety information, intellectual property management, income and expenditure management, public relations and planning coordination, and the "KOBE Monowager Network Secretariat". increase. In addition, we supervise clerical work within the Clinical Research and Innovation and work closely with other departments to provide clerical support for the smooth implementation of clinical research and trials.

Clinical trial results (by fiscal year)

Main clinical departments and target diseases

The Clinical Training Promotion Center is located in the main building and the south building of the Kobe City Medical Center.

If you are a clinical research coordinator (CRC) at our hospital, please come to the following branch office.

Clinical Research and Innovation Headquarters (South Building 4F)

〒650-0047
Minatojima Minamimachi Chuo-ku, Kobe City

Enter the port liner entrance and take the elevator on the left to the 4th floor.

Clinical Research and Innovation Branch Office (Main Building 3F)

〒650-0047
Minatojima Minamimachi Chuo-ku, Kobe City

Patient consultation desk for clinical trials and clinical research

〒650-0047
Minatojima Minamimachi Chuo-ku, Kobe City
Clinical Research and Innovation
TEL: (078) 302-4448 *Telephone reception hours are 9:00-17:00 on weekdays
Fax: (078) 302-4604
Email: c_ccri1at-kcho.jp

*To prevent spam, please replace "at" with @ in the email address.

Clinical trial contact information from the sponsor

TEL：078-302-4499 ※電話応対は平日9:00～17:00
Mail：c_ccriあっとkcho.jp

*To prevent spam, please replace "at" with @ in the email address.

Contact information for clinical research from researchers and companies

TEL：078-302-4499 ※電話応対は平日9:00～17:00
Mail：rinkenあっとkcho.jp

*To prevent spam, please replace "at" with @ in the email address.

Contact information for specific clinical research from researchers and companies

TEL：078-302-4499 ※電話応対は平日9:00～17:00
Mail：c_tokuteiあっとkcho.jp

*To prevent spam, please replace "at" with @ in the email address.

Point of contact for general post-marketing surveillance

TEL：078-302-4499 ※電話応対は平日9:00～17:00
Mail：chikenあっとkcho.jp

*To prevent spam, please replace "at" with @ in the email address.